NCT06543966View on ClinicalTrials.gov

Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

486

Participants

Timeline

Start Date

October 28, 2024

Primary Completion Date

March 28, 2026

Study Completion Date

March 28, 2026

Conditions
Post-operative Nausea and Vomiting (PONV)
Interventions
DRUG

Aprepitant Injection

Before anesthesia induction, 4.4ml(32mg） was given by a single intravenous injection, which was completed within 30 seconds

DRUG

Aprepitant Injection Placebo

Before anesthesia induction, 4.4ml(0mg） was given by a single intravenous injection, which was completed within 30 seconds

All Listed Sponsors
lead

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

INDUSTRY

NCT06543966 - Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting | Biotech Hunter | Biotech Hunter